ROW. AstraZeneca shall be the lead regulatory Party in the RoW for all Products and indications.
Appears in 3 contracts
Sources: License, Development and Commercialization Agreement (Fibrogen Inc), License, Development and Commercialization Agreement (Fibrogen Inc), License, Development and Commercialization Agreement (Fibrogen Inc)